InvestorsHub Logo
Followers 1
Posts 129
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Thursday, 06/27/2013 12:21:57 PM

Thursday, June 27, 2013 12:21:57 PM

Post# of 12383
Maybe Tak Mak is persuing CFI-400945 for Entremed. He may be able to argue to the Canadians that Entremed is the best home for it because he would be able to maintain control over it, as opposed to selling it to some large cap biotech. Even though Entremed may not be able to afford a huge up front payment, they may be able to offer more in royalties and ownership. Tak is familiar with the compound, and may be the best person on earth to oversee its' developement. Even more so if it has synergistic weth 2076. He has proven that he is a great scientist, lets see if his business prowness is as spectacular. The acquisition would put Entremed back on the radar.